BIO-Europe Spring® 2016: Getting to know EUSA Pharma 2.0

April 19, 2016
EUSA Pharma, initially formed in 2006 but later acquired by Jazz Pharmaceuticals in 2012, was reborn last year with a fresh new focus on specialty products in the oncology space. Business development director, Benjamin Owens, spoke with Scrip reporter Lucie Ellis about EUSA's big plans for global expansion. The pharma will target Spain, Italy and the Nordics in the near future and is also focused on securing a strong US presence through collaborations and acquisitions.
Previous Video
BIO-Europe Spring® 2016: CEVEC CEO talks US deals to expand business
BIO-Europe Spring® 2016: CEVEC CEO talks US deals to expand business

Frank Ubags, CEO of CEVEC—a company offering industrial scale production of viral vectors for gene therapy ...

Next Video
BIO-Europe Spring® 2016: AstraZeneca BD head says more out-licensing divestment expected in 2016
BIO-Europe Spring® 2016: AstraZeneca BD head says more out-licensing divestment expected in 2016

AstraZeneca PLC's head of strategic partnering and business development, Shaun Grady, tells Pharma Intellig...